These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 1938129)
21. Central administration of the endopeptidase 24.15 inhibitor cFP-AAF-pAB suggests dynorphin as the endogenous ligand underlying behavioral effects of milk in the fetal rat. Smotherman WP; Robinson SR; Varlinskaya EI; Petrov ES; Orlowski M; de Costa BR; Rice KC Pharmacol Biochem Behav; 1994 Mar; 47(3):715-9. PubMed ID: 7911578 [TBL] [Abstract][Full Text] [Related]
22. Characteristic of antinociceptive effect of a tetrapeptide, Asn-Ala-Gly-Ala (NAGA). Iijima M; Kubota K; Matsuoka Y; Uruno T; Satoh S; Ueki M; Matsui S J Pharmacobiodyn; 1985 Jul; 8(7):549-56. PubMed ID: 4067816 [TBL] [Abstract][Full Text] [Related]
23. Intracerebroventricular infusion of inhibitors of endopeptidase-24.11 ('enkephalinase') increases the spontaneous firing frequency of an identifiable set of cells in the substantia nigra. Bier MJ; Goldfarb J; Orlowski M; Wilk S Eur J Pharmacol; 1987 Oct; 142(3):321-30. PubMed ID: 3480807 [TBL] [Abstract][Full Text] [Related]
24. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors. Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815 [TBL] [Abstract][Full Text] [Related]
25. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors. Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845 [TBL] [Abstract][Full Text] [Related]
26. Rationally designed chimeric peptide of met-enkephalin and FMRFa-[D-Ala2,p-Cl-Phe4]YFa induce multiple opioid receptors mediated antinociception and up-regulate their expression. Vats ID; Chaudhary S; Sharma A; Nath M; Pasha S Eur J Pharmacol; 2010 Jul; 638(1-3):54-60. PubMed ID: 20385120 [TBL] [Abstract][Full Text] [Related]
27. Inhibitors of metalloendopeptidase EC 3.4.24.15 and EC 3.4.24.16 stabilized against proteolysis by the incorporation of beta-amino acids. Steer D; Lew R; Perlmutter P; Smith AI; Aguilar MI Biochemistry; 2002 Sep; 41(35):10819-26. PubMed ID: 12196021 [TBL] [Abstract][Full Text] [Related]
28. Effects of intracerebroventricularly administered chimeric peptide of metenkephalin and FMRFa--[D-Ala2]YFa-on antinociception and its modulation in mice. Gupta S; Pasha S; Gupta YK; Bhardwaj DK Brain Res Bull; 2001 May; 55(1):51-7. PubMed ID: 11427337 [TBL] [Abstract][Full Text] [Related]
29. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits. Tomoda F; Lew RA; Smith AI; Madden AC; Evans RG Br J Pharmacol; 1996 Sep; 119(2):365-73. PubMed ID: 8886422 [TBL] [Abstract][Full Text] [Related]
31. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice. Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958 [TBL] [Abstract][Full Text] [Related]
33. Involvement of spinal release of α-neo-endorphin on the antinociceptive effect of TAPA. Mizoguchi H; Kon-No T; Watanabe H; Watanabe C; Yonezawa A; Sato T; Sakurada T; Sakurada S Peptides; 2013 Dec; 50():139-44. PubMed ID: 24126280 [TBL] [Abstract][Full Text] [Related]
34. Effect of a novel selective and potent phosphinic peptide inhibitor of endopeptidase 3.4.24.16 on neurotensin-induced analgesia and neuronal inactivation. Vincent B; Jiracek J; Noble F; Loog M; Roques B; Dive V; Vincent JP; Checler F Br J Pharmacol; 1997 Jun; 121(4):705-10. PubMed ID: 9208137 [TBL] [Abstract][Full Text] [Related]
35. Antinociceptive effect of intracerebroventricular injection of a tetrapeptide Asn-Ala-Gly-Ala in rats. He C; Song CY; Wei YM; You ZD; Shi PT Zhongguo Yao Li Xue Bao; 1994 Nov; 15(6):497-500. PubMed ID: 7709746 [TBL] [Abstract][Full Text] [Related]
36. Spinorphin, an endogenous inhibitor of enkephalin-degrading enzymes, potentiates leu-enkephalin-induced anti-allodynic and antinociceptive effects in mice. Honda M; Okutsu H; Matsuura T; Miyagi T; Yamamoto Y; Hazato T; Ono H Jpn J Pharmacol; 2001 Dec; 87(4):261-7. PubMed ID: 11829145 [TBL] [Abstract][Full Text] [Related]
37. Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouse. Jinsmaa Y; Fujita Y; Shiotani K; Miyazaki A; Li T; Tsuda Y; Okada Y; Ambo A; Sasaki Y; Bryant SD; Lazarus LH Eur J Pharmacol; 2005 Feb; 509(1):37-42. PubMed ID: 15713427 [TBL] [Abstract][Full Text] [Related]
38. Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs. Gouardères C; Sutak M; Zajac JM; Jhamandas K Eur J Pharmacol; 2000 Oct; 406(3):391-401. PubMed ID: 11040346 [TBL] [Abstract][Full Text] [Related]
39. Contribution of spinal mu(1)-opioid receptors and dynorphin B to the antinociception induced by Tyr-d-Arg-Phe-Sar. Mizoguchi H; Ito K; Watanabe H; Watanabe C; Katsuyama S; Fujimura T; Sakurada T; Sakurada S Peptides; 2006 Nov; 27(11):2786-93. PubMed ID: 16919848 [TBL] [Abstract][Full Text] [Related]